Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02343913
Other study ID # 6005a
Secondary ID
Status Completed
Phase N/A
First received January 16, 2015
Last updated March 2, 2015
Start date June 2014
Est. completion date December 2014

Study information

Verified date March 2015
Source Gynuity Health Projects
Contact n/a
Is FDA regulated No
Health authority Pakistan: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

This study is an additional component of protocol 6005, titled Simplifying Menstrual Regulation (MR): Exploring the role of at-home semi-quantitative pregnancy tests for follow-up to menstrual regulation service provision in Pakistan. The study seeks to pilot a self-assessment checklist that will help women, who receive medical services for incomplete abortion, correctly identify warning signs and symptoms and determine whether to return to the clinic. The checklist can serve as a useful resource to help with the timely identification of women who need additional care and can help streamline service delivery. In addition, this study will provide important data on the role of misoprostol at varying levels of health services offering an array of treatments for incomplete abortion.


Recruitment information / eligibility

Status Completed
Enrollment 329
Est. completion date December 2014
Est. primary completion date November 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Vaginal bleeding during pregnancy

- Open cervical os.

- No signs of severe infection, defined as at least one of the following of: 1) foul smelling discharge, 2) fever > 38 degrees C , 3) uterine tenderness

- No hemodynamic disturbances (pulse >110/min and systolic bp <100)

Exclusion Criteria:

- Suspected to have an ectopic pregnancy

- Unable to provide informed consent

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Device:
PAC checklist


Locations

Country Name City State
Pakistan BagaSher Service Delivery Clinic BagaSher Muzaffargarh
Pakistan Bahari Colony Service Delivery Clinic Bahari Colony Rawalpindi
Pakistan Bhagwal Service Delivery Clinic Bhagwal Chakwal
Pakistan Chakumra Service Delivery Clinic Chakumra Chakwal
Pakistan Model Clinic Chakwal Chakwal
Pakistan Dasrat Colony Service Delivery Clinic Dasrat Colony Muzaffargarh
Pakistan DhokeHasso Service Delivery Clinic DhokeHasso Rawalpindi
Pakistan Chak 128 GB Service Delivery Clinic Faisalabad
Pakistan Model Clinic Faisalabad Faisalabad
Pakistan Fazal Nagal Service Delivery Clinic Fazal Nagal Muzaffargarh
Pakistan Family Health Hospital Islamabad
Pakistan Karrila Service Delivery Clinic Karrila Chakwal
Pakistan Khanpur Service Delivery Clinic Khanpur Chakwal
Pakistan Family Health Hospital Lahore
Pakistan Sabe wala clinic Muzaffargarh

Sponsors (2)

Lead Sponsor Collaborator
Gynuity Health Projects Family Planning Association Pakistan

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Identify symptoms Proportion of women able to use a checklist to correctly identify any signs and symptoms that warrant immediate return to the clinic and additional care 1 week No
Secondary Acceptability of treatment Proportion of women who find the treatment of 400 sublingual misoprostol for incomplete abortion acceptable and satisfactory. 1 week No
Secondary Uptake of contraceptive use Proportion of women who receive a contraceptive method after receipt of 400 sublingual misoprostol 1 week No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02745093 - Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks Phase 4
Completed NCT02570204 - Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests N/A
Completed NCT01487213 - Routine Follow-up Versus Self-assessment in Medical Abortion N/A
Terminated NCT05119439 - Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks Phase 4
Terminated NCT04941443 - Methadone and Medication Abortion Phase 4
Completed NCT02985229 - Acceptability and Feasibility of Medical Abortion in Singapore Phase 3
Completed NCT01920022 - Quickstart of Nexplanon® at Medical Abortion Phase 4
Completed NCT00472394 - Determining Women's Preferences for Medical Abortion Using Willingness to Pay N/A
Completed NCT03604341 - Cannabinoids for Pain Control During Medical Abortion Phase 4
Completed NCT00907725 - Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion? N/A
Completed NCT00120224 - De-Medicalizing Mifepristone Medical Abortion N/A
Completed NCT03148587 - Medical Abortion Self-Confirmation (MASC) N/A
Completed NCT00621543 - Insertion of an Intrauterine Device (IUD) After Medical Abortion N/A
Completed NCT01856777 - Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy N/A
Recruiting NCT00920465 - Treatment Regimens for Mifegyne and Cytotec Phase 3
Completed NCT05532085 - Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
Completed NCT00997347 - The Extended Gestational Age Medical Abortion Study Phase 4
Completed NCT03014193 - Simplifying First Trimester Medical Abortion Follow-up N/A
Recruiting NCT04905251 - Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion
Completed NCT04181541 - Midlevel Versus Physician-provided Medical Abortion in the Second Trimester N/A